| Midmochiro L.l.c. | |
|
101 Redtail Dr Ste A Ashland MO 65010-1140 | |
| (573) 657-2500 | |
| (573) 657-2502 |
| Full Name | Midmochiro L.l.c. |
|---|---|
| Speciality | Clinic/Center |
| Location | 101 Redtail Dr Ste A, Ashland, Missouri |
| Authorized Official Name and Position | James William Zielinski (OWNER) |
| Authorized Official Contact | 5736572500 |
| Accepts Medicare Insurance | Yes. This clinic participates in medicare program and accept medicare insurance. |
| Mailing Address | Practice Location Address |
|---|---|
| Midmochiro L.l.c. 101 Redtail Dr Ste A Ashland MO 65010-1140 Ph: (573) 657-2500 | Midmochiro L.l.c. 101 Redtail Dr Ste A Ashland MO 65010-1140 Ph: (573) 657-2500 |
| NPI Number | 1982474367 |
|---|---|
| Provider Enumeration Date | 01/05/2024 |
| Last Update Date | 01/05/2024 |
| Medicare PECOS PAC ID | 8628411006 |
|---|---|
| Medicare Enrollment ID | O20240213003099 |
News Archive
Noven Pharmaceuticals, Inc., a wholly-owned subsidiary of Hisamitsu Pharmaceutical Co., Inc., today announced commencement of a Phase 2 study of a d-Amphetamine Transdermal System (d-ATS) for the treatment of Attention Deficit Hyperactivity Disorder (ADHD) in children and adolescents. Currently, there is no approved amphetamine-based transdermal treatment option available for ADHD.
Biotech company Pharming Group NV ("Pharming" or "the Company") today received confirmation of validation from EMEA of its Marketing Authorization Application (MAA) for Rhucin.
Last month, U.S. Army medical residents and their program directors from around the country attended the American College of Physicians' (ACP) annual meeting to present their research, compete in national medical student abstract competitions and share their perspective as military officers with civilian peers. Three Army medical residents earned national awards for their research.
The American College of Allergy, Asthma and Immunology and the American Gastroenterological Association Institute today announced an innovative initiative called "HAE: Learn About It, Talk About It," at Digestive Disease Week® 2010.
› Verified 8 days ago
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1982474367 | NPI | - | NPPES |
| Provider Name | James W Zielinski |
|---|---|
| Provider Type | Practitioner - Chiropractic |
| Provider Identifiers | NPI Number: 1528231164 PECOS PAC ID: 6406920941 Enrollment ID: I20180606002447 |
News Archive
Noven Pharmaceuticals, Inc., a wholly-owned subsidiary of Hisamitsu Pharmaceutical Co., Inc., today announced commencement of a Phase 2 study of a d-Amphetamine Transdermal System (d-ATS) for the treatment of Attention Deficit Hyperactivity Disorder (ADHD) in children and adolescents. Currently, there is no approved amphetamine-based transdermal treatment option available for ADHD.
Biotech company Pharming Group NV ("Pharming" or "the Company") today received confirmation of validation from EMEA of its Marketing Authorization Application (MAA) for Rhucin.
Last month, U.S. Army medical residents and their program directors from around the country attended the American College of Physicians' (ACP) annual meeting to present their research, compete in national medical student abstract competitions and share their perspective as military officers with civilian peers. Three Army medical residents earned national awards for their research.
The American College of Allergy, Asthma and Immunology and the American Gastroenterological Association Institute today announced an innovative initiative called "HAE: Learn About It, Talk About It," at Digestive Disease Week® 2010.
› Verified 8 days ago
News Archive
Noven Pharmaceuticals, Inc., a wholly-owned subsidiary of Hisamitsu Pharmaceutical Co., Inc., today announced commencement of a Phase 2 study of a d-Amphetamine Transdermal System (d-ATS) for the treatment of Attention Deficit Hyperactivity Disorder (ADHD) in children and adolescents. Currently, there is no approved amphetamine-based transdermal treatment option available for ADHD.
Biotech company Pharming Group NV ("Pharming" or "the Company") today received confirmation of validation from EMEA of its Marketing Authorization Application (MAA) for Rhucin.
Last month, U.S. Army medical residents and their program directors from around the country attended the American College of Physicians' (ACP) annual meeting to present their research, compete in national medical student abstract competitions and share their perspective as military officers with civilian peers. Three Army medical residents earned national awards for their research.
The American College of Allergy, Asthma and Immunology and the American Gastroenterological Association Institute today announced an innovative initiative called "HAE: Learn About It, Talk About It," at Digestive Disease Week® 2010.
› Verified 8 days ago
University Physicians Specialty Care Associates Primary Care Clinic Medicare: Not Enrolled in Medicare Practice Location: 605 Douglas Dr # C, Ashland, MO 65010 Phone: 573-882-9060 Fax: 573-657-0122 | |
Southern Boone County Family Care Primary Care Clinic Medicare: Not Enrolled in Medicare Practice Location: 605c Douglas Dr, Ashland, MO 65010 Phone: 573-657-9354 | |
Research To Practice, Inc. Primary Care Clinic Medicare: Not Enrolled in Medicare Practice Location: 105 Oak St Ste A, Ashland, MO 65010 Phone: 573-489-4850 | |
University Physicians Primary Care Clinic Medicare: Not Enrolled in Medicare Practice Location: 605 Douglas Dr # C, Ashland, MO 65010 Phone: 573-882-2215 | |
University Physicians Specialty Care Associates Primary Care Clinic Medicare: Not Enrolled in Medicare Practice Location: 101 Redtail Dr Ste C, Ashland, MO 65010 Phone: 573-882-9060 | |
Honeycomb Health Llc Primary Care Clinic Medicare: Not Enrolled in Medicare Practice Location: 14510 S Kidwell Ct, Ashland, MO 65010 Phone: 573-508-0662 Fax: 573-415-8082 |